PTX3 is expressed in terminal lymphatics and shapes their organization and function

Front Immunol. 2024 Nov 21:15:1426869. doi: 10.3389/fimmu.2024.1426869. eCollection 2024.

Abstract

Introduction: The lymphatic system is a multifaceted regulator of tissue homeostasis and an integral part of immune responses. Previous studies had shown that subsets of lymphatic endothelial cells (LEC) express PTX3, an essential component of humoral innate immunity and tissue homeostasis.

Methods: In the present study using whole-mount imaging and image-based morphometric quantifications, Ptx3-targeted mice and in vivo functional analysis, we investigated the involvement of PTX3 in shaping and function of the lymphatic vasculature.

Results: We found that PTX3 is localized in the extracellular matrix (ECM) surrounding human and murine lymphatic vessels (LV). In murine tissues, PTX3 was localized in the ECM close to LV terminals and sprouting. Ptx3-deficient mice showed LV abnormalities in the colon submucosa and diaphragm, including a disorganized pattern and hyperplasia of initial LV capillaries associated with altered distribution of tight junction-associated molecules. Mice with LEC-restricted PTX3 gene inactivation showed morphological and organization abnormalities similar to those observed in Ptx3-deficient animals. Ptx3-deficient mice showed defective fluid drainage from footpads and defective dendritic cell (DC) trafficking.

Discussion: Thus, PTX3 is strategically localized in the ECM of specialized LV, playing an essential role in their structural organization and immunological function.

Keywords: extracellular matrix; innate immunity; lymphatic system; pattern recognition molecule; tissue homeostasis.

MeSH terms

  • Animals
  • C-Reactive Protein / genetics
  • C-Reactive Protein / metabolism
  • Dendritic Cells / immunology
  • Dendritic Cells / metabolism
  • Endothelial Cells* / metabolism
  • Extracellular Matrix / metabolism
  • Humans
  • Lymphatic Vessels* / metabolism
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout*
  • Serum Amyloid P-Component / genetics
  • Serum Amyloid P-Component / metabolism

Substances

  • C-Reactive Protein
  • PTX3 protein
  • Serum Amyloid P-Component

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This study has received funding from Associazione Italiana Ricerca sul Cancro (AIRC) “Regulatory pathways of myeloid cells, inflammation and cancer” (grant IG-2019 N. 23465).